MedPath
TGA Approval

GENVOYA elvitegravir (150mg), cobicistat (150mg), emtricitabine (200mg) and tenofovir alafenamide (as fumarate) (10mg) fixed dose combination tablets (233398)

233398

GENVOYA elvitegravir (150mg), cobicistat (150mg), emtricitabine (200mg) and tenofovir alafenamide (as fumarate) (10mg) fixed dose combination tablets

Gilead Sciences Pty Ltd

January 15, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/8b8af93a27178a0153acfd60d9633aac.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/bebf943d5fede5f90e86d78582d5f536.pdf

Active Ingredients

cobicistat

elvitegravir

emtricitabine

tenofovir alafenamide fumarate

© Copyright 2025. All Rights Reserved by MedPath